Advertisement
Advertisement

CING

CING logo

Cingulate Inc. Common Stock

5.34
USD
Sponsored
+0.29
+5.74%
Aug 07, 15:59 UTC -4
Closed
exchange

Pre-Market

5.25

-0.09
-1.69%

Cingulate Inc. Common Stock Profile

About

Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) drug delivery platform technology to build and advance a pipeline of pharmaceutical products. Cingulate Inc. is based in KANSAS CITY, Kan.

Info & Links

CEO

Shane J. Schaffer

Headquarters

1901 W. 47TH PLACE
KANSAS CITY, KS 66205, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cingulate.com

Auditor

KPMG LLP

Share holders

209

Employees

14

Cingulate Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

70.71M

Enterprise Value

50.97M

Enterprise Value/EBITDA(ttm)

-2.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-365.15%

Return on Invested Capital(ttm)

-524.26%

Return on Assets(ttm)

-158.55%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-23.70M

Net Income Available to Common(ttm)

-27.91M

Diluted EPS(ttm)

-4.23

Share Statistics

Beta (5Y Monthly)

-0.90

52-Week Change

28.06%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

13.28M

Dividend Yield

0.00%

Float4

12.76M

% Held by Insiders

5.30%

% Held by Institutions

41.31%

Balance Sheet

Total Cash(mrq)

25.89M

Total Cash Per Share(mrq)

1.95

Total Debt(mrq)

6.15M

Total Debt/Equity(mrq)

32.58%

Current Ratio(mrq)

2.55%

Quick Ratio(mrq)

2.55%

Book Value Per Share(mrq)

1.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.71

Free Cash Flow(ytd)

-6.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement